Zentalis Pharmaceuticalsllc Stock Z Score
| ZNTL Stock | USD 13.27 0.14 1.04% |
Zentalis | Z Score |
Zentalis PharmaceuticalsLlc Company Z Score Analysis
Zentalis PharmaceuticalsL's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Zentalis Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Zentalis PharmaceuticalsL is extremely important. It helps to project a fair market value of Zentalis Stock properly, considering its historical fundamentals such as Z Score. Since Zentalis PharmaceuticalsL's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zentalis PharmaceuticalsL's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zentalis PharmaceuticalsL's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
As per the company's disclosures, Zentalis PharmaceuticalsLlc has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Zentalis Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zentalis PharmaceuticalsL's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zentalis PharmaceuticalsL could also be used in its relative valuation, which is a method of valuing Zentalis PharmaceuticalsL by comparing valuation metrics of similar companies.Zentalis PharmaceuticalsL is currently under evaluation in z score category among related companies.
Zentalis PharmaceuticalsL Institutional Holders
Institutional Holdings refers to the ownership stake in Zentalis PharmaceuticalsL that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Zentalis PharmaceuticalsL's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zentalis PharmaceuticalsL's value.| Shares | Decheng Capital Llc | 2023-12-31 | 2.1 M | Woodline Partners Lp | 2023-12-31 | 1.4 M | Geode Capital Management, Llc | 2023-12-31 | 1.3 M | Primecap Management Company | 2023-12-31 | 1 M | Tybourne Capital Management (hk) Ltd | 2023-12-31 | 961.5 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 724 K | Bank Of America Corp | 2023-12-31 | 718.6 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 609.5 K | Goldman Sachs Group Inc | 2023-12-31 | 585.8 K | Matrix Capital Management Company, Llc | 2023-12-31 | 14 M | Eventide Asset Management, Llc | 2023-12-31 | 11.6 M |
Zentalis Fundamentals
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 514.54 M | ||||
| Shares Outstanding | 70.96 M | ||||
| Shares Owned By Insiders | 4.22 % | ||||
| Shares Owned By Institutions | 95.78 % | ||||
| Number Of Shares Shorted | 15.53 M | ||||
| Price To Book | 2.18 X | ||||
| EBITDA | (252.55 M) | ||||
| Net Income | (292.19 M) | ||||
| Cash And Equivalents | 455.22 M | ||||
| Cash Per Share | 7.99 X | ||||
| Total Debt | 45.77 M | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 9.61 X | ||||
| Book Value Per Share | 6.18 X | ||||
| Cash Flow From Operations | (207.82 M) | ||||
| Short Ratio | 16.26 X | ||||
| Earnings Per Share | (4.47) X | ||||
| Target Price | 34.4 | ||||
| Number Of Employees | 124 | ||||
| Beta | 1.73 | ||||
| Market Capitalization | 951.58 M | ||||
| Total Asset | 562.03 M | ||||
| Retained Earnings | (888.56 M) | ||||
| Working Capital | 427.35 M | ||||
| Net Asset | 562.03 M |
About Zentalis PharmaceuticalsL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zentalis PharmaceuticalsLlc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zentalis PharmaceuticalsL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zentalis PharmaceuticalsLlc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink |
Check out Zentalis PharmaceuticalsL Piotroski F Score and Zentalis PharmaceuticalsL Valuation analysis. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.